APP announces business separation

APP announces business separation

SCHAUMBURG -- APP Pharmaceuticals Inc. announced it completed the tax-free separation of its proprietary business. APP Pharmaceuticals is a manufacturer of multi-source and branded injectable pharmaceutical products for acute medical care, both in patient and ambulatory settings. Through its broad portfolio of therapeutic products, APP helps provide ongoing affordable health care for millions of people in the United States and Canada fighting critical illnesses.